menu
Presentation
Victor Weigman, Ph.D. | December 05, 2019

New Tools and Strategies for High Quality TMB Analysis by NGS

Presented at AMP 2019
In this presentation, you will learn:
  • Q2 Solutions' overall approach to supporting clinical trial testing
  • Analytical assay challenges considering panels vs. Whole Exome Sequencing (WES)
  • Lessons learned from Friends of Cancer Research regarding TMB harmonization
  • Importance of reference materials establishing assay validation, QC, and future needs in Immuno-oncology

Related Services:
Genomics Laboratory Sequencing Capabilities

Global genomic testing services to support drug discovery, precision medicine, and clinical development

The standardization of Tumor Mutational Burden (TMB) by alignments to reference standards

Joined by Friends of Cancer Research (Friends)

The importance of TMB standardization for diagnostic assays

Standardization of TMB scores by using a common set of reference standards

Tumor Mutational Burden (TMB) Assay for Response to Immunotherapy

TMB assay utilizing whole exome sequencing (WES) methodology and proprietary variant analysis compendium

Read More